Transposagen Biopharmaceuticals' Grant - II Round

Transposagen Biopharmaceuticals raised a round of funding on June 21, 2013. Investors include National Institutes of Health.

Transposagen Biopharmaceuticals produces genetically modified MutaRat Knockout Animal Models of human diseases for drug discovery and development. Per the company, the production of animal models is …

Articles about Transposagen Biopharmaceuticals' Grant - II Round: